Concepedia

Geertje J. Dreyer

GJ

Statistics

Publications

6

Citations

296

H-Index

6

Active since

2013

Affiliations

Leiden University Medical Center(Current)

KU Leuven

Geertje J. Dreyer is an author at Leiden University Medical Center specializing in cellular therapies, hematology, and medicine.

ORCID

Top concepts

Publications per year

2013–2023

6

Publications

6

Autologous bone marrow derived mesenchymal stromal cell therapy in combination with everolimus to preserve renal structure and function in renal transplant recipients

Marlies E. J. Reinders, Jonna R. Bank, Geertje J. Dreyer et al. · Journal of Translational Medicine · 2014 · 75 citations · Full text

Safety of allogeneic bone marrow derived mesenchymal stromal cell therapy in renal transplant recipients: the neptune study

Marlies E. J. Reinders, Geertje J. Dreyer, Jonna R. Bank et al. · Journal of Translational Medicine · 2015 · 66 citations · Full text

Triple negative breast cancer: Clinical characteristics in the different histological subtypes

Geertje J. Dreyer, T. Vandorpe, Ann Smeets et al. · The Breast · 2013 · 59 citations · Full text

Human leukocyte antigen selected allogeneic mesenchymal stromal cell therapy in renal transplantation: The Neptune study, a phase I single-center study

Geertje J. Dreyer, Koen E. Groeneweg, Sebastiaan Heidt et al. · American Journal of Transplantation · 2020 · 42 citations · Full text

Autologous bone marrow-derived mesenchymal stromal cell therapy with early tacrolimus withdrawal: The randomized prospective, single-center, open-label TRITON study

Marlies E. J. Reinders, Koen E. Groeneweg, Sanne H. Hendriks et al. · American Journal of Transplantation · 2021 · 38 citations · Full text

, , +12

1–5 of 6